For example, silencing of the ceramide transporter CERT was shown to confer sensitivity to paclitaxel across multiple cancer cell lines and follow-up analysis revealed that CERT was overexpressed in two separate paclitaxel-resistant cell lines. The gene discussed is CERT1; the disease is cancer.